Citation Impact
Citing Papers
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Cyclodextrins: Their Future in Drug Formulation and Delivery
1997
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice
2000 StandoutNobel
Experimental models of inflammatory bowel disease
1995 Standout
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Embryo Implantation
2000 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Emerging organic contaminants in groundwater: A review of sources, fate and occurrence
2012 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
2017
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Isolation, structures and bioactivities of the polysaccharides from jujube fruit (Ziziphus jujuba Mill.): A review
2017 Standout
Rapid hydrophilic interaction chromatography determination of lysine in pharmaceutical preparations with fluorescence detection after postcolumn derivatization with o-phtaldialdehyde
2010
Role of M Cells in Intestinal Barrier Function
2000
Clinical Pharmacokinetics of Ibuprofen
1998
Hydrophilic interaction chromatography
2006 Standout
The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine
2011
Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats
1998
Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified Cyclodextrins
1991
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Characterization of Prostaglandin H Synthase 2 Deficient Mice and Implications for Mechanisms of NSAID Action
1997 StandoutNobel
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
2001 StandoutNobel
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
1996
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
2005 StandoutNobel
Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2
2000 Standout
Mechanisms of acute and chronic intestinal inflammation induced by indomethacin
1993
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Ecotoxicology of human pharmaceuticals
2005 Standout
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
2001 Standout
Development and validation of a high-performance liquid chromatographic method for the quantitation of warfarin enantiomers in human plasma
1993
The Relation Between Swelling Properties and Enzymatic Degradation of Azo Polymers Designed for Colon-Specific Drug Delivery
1994
Imprinting Chemical and Responsive Micropatterns into Metal–Organic Frameworks
2010 StandoutNobel
Direct enantiomeric separations by high performance liquid chromatography using cyclodextrins
1997
NSAIDs: the Emperor’s new dogma?
2003
COX-2 inhibitors
1999 Standout
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
2002
Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data
2002 Standout
Hydrophilic interaction liquid chromatography (HILIC)—a powerful separation technique
2011 Standout
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
A Controlled Study Comparing the Effects of Nabumetone, Ibuprofen, and Ibuprofen Plus Misoprostol on the Upper Gastrointestinal Tract Mucosa
1993
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats
1995
Imprinting Chemical and Responsive Micropatterns into Metal–Organic Frameworks
2010 StandoutNobel
Cyclodextrins in drug delivery
2005
Photochemically induced fluorescence investigation of a?-cyclodextrin: Azure A inclusion complex and determination of analytical parameters
1995
Polymeric Systems for Controlled Drug Release
1999 Standout
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
A Sulfated-Polysaccharide Fraction from Seaweed Gracilaria birdiae Prevents Naproxen-Induced Gastrointestinal Damage in Rats
2012
Cyclodextrin Drug Carrier Systems
1998 Standout
Review: A History of Cyclodextrins
2014 Standout
Drug Solubility: Importance and Enhancement Techniques
2012 Standout
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
2000 StandoutNobel
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Colonic drug-targeting: In vitro release of ibuprofen from capsules coated with poly(ether-ester) azopolymers
1996
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Pharmaceuticals and personal care products in the environment: agents of subtle change?
1999 Standout
Plastic and Human Health: A Micro Issue?
2017 Standout
Prostaglandins and Inflammation
2011 Standout
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Cyclodextrins and their uses: a review
2003 Standout
Mechanisms of drug release from cyclodextrin complexes
1999
Occurrence and Environmental Behavior of the Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in Wastewater
1999
Works of K. Dietzel being referenced
Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats
1990
A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat.
1991
Recent Insight into the Mechanism of Gastrointestinal Tract Ulceration
1987
High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids
1989
The use of 2-hydroxypropyl-β-cyclodextrin as a vehicle for intravenous administration of dexamethasone in dogs
1990
Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid.
1989
Biliary elimination of non‐steroidal anti‐inflammatory drugs in patients.
1990